← Back to Search

Contingency Management Strategies for Opioid Use Disorder (MIMIC Trial)

N/A

Waitlist Available

Led By Bryan R Garner, Ph.D.

Research Sponsored by Brown University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

prescribes FDA-approved medication to treat adult patients with OUDs

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed at 3 and 6-months from patient baseline assessment

Awards & highlights

MIMIC Trial Summary

This trial will study how to best implement contingency management, an evidence-based treatment for opioid use disorder, in order to improve patient outcomes.

Who is the study for?

This trial is for opioid treatment centers that have at least two staff members providing psychosocial support to patients with Opioid Use Disorder (OUD), see five or more new patients monthly, and prescribe FDA-approved medication for treating adults with OUDs.Check my eligibility

What is being tested?

The study compares two training strategies to implement contingency management in opioid treatment centers. The control group uses standard ATTC training, while the experimental group gets enhanced ATTC training with leadership coaching and provider incentives.See study design

What are the potential side effects?

Since this trial focuses on implementation strategies rather than direct patient interventions, it does not involve medical side effects. However, there may be indirect impacts on patient care based on the effectiveness of each strategy.

MIMIC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am prescribed FDA-approved medication for opioid use disorder.

MIMIC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed at 3 and 6-months from patient baseline assessment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed at 3 and 6-months from patient baseline assessment

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 3 and 6-months from patient baseline assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

CM Competence (implementation outcome)

CM Sustainment (implementation outcome)

CM exposure (implementation outcome)

Secondary outcome measures

Opioid Abstinence: Past Month (patient outcome)

Opioid-Related Problems: Past Month (patient outcome)

Other outcome measures

Implementation Climate

Leadership Engagement

MIMIC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Enhanced ATTC (E-ATTC) Training StrategyExperimental Treatment1 Intervention

Half of the opioid treatment centers will receive the E-ATTC training strategy.

Group II: Addiction Technology Transfer Center (ATTC) TrainingActive Control1 Intervention

Half of the opioid treatment centers will receive the ATTC training strategy.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor

456 Previous Clinical Trials

562,121 Total Patients Enrolled

RTI InternationalOTHER

188 Previous Clinical Trials

875,004 Total Patients Enrolled

University of WashingtonOTHER

1,738 Previous Clinical Trials

1,843,391 Total Patients Enrolled

Media Library

Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy Clinical Trial Eligibility Overview. Trial Name: NCT03931174 — N/A

Opioid Use Disorder Research Study Groups: Addiction Technology Transfer Center (ATTC) Training, Enhanced ATTC (E-ATTC) Training Strategy

Opioid Use Disorder Clinical Trial 2023: Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy Highlights & Side Effects. Trial Name: NCT03931174 — N/A

Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03931174 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there many medical facilities that are presently conducting this research in North America?

"A variety of medical centres are now enrolling, including Spectrum Health Systems in North Adams, Lifespan Recovery Center Pittsfield and other 15 sites."

Answered by AI

How many individuals can enroll in this research endeavor?

"To meet the study's requirements, 960 qualified individuals must participate. Those eligible can join this trial at either Spectrum Health Systems in North Adams, Rhode island or Spectrum Health Systems Pittsfield in Southbridge, Connecticut."

Answered by AI

Can any new participants still join the experiment?

"Affirmative, the information located on clinicaltrials.gov attests to this trial actively searching for participants. It was initially launched in April of 2019 and is currently accepting 960 applicants across 17 different sites with its most recent update being November 19th 2021."

Answered by AI

Recent research and studies

Addiction Science & Clinical PracticeJournal

Project MIMIC (maximizing Implementation of Motivational Incentives in Clinics): A Cluster-randomized Type 3 Hybrid Effectiveness-implementation Trial

Becker, Sara J., Cara M. Murphy, Bryan Hartzler, Carla J. Rash, Tim Janssen, Mat Roosa, Lynn M. Madden, and Bryan R. Garner. 2021. “Project MIMIC (maximizing Implementation of Motivational Incentives in Clinics): A Cluster-randomized Type 3 Hybrid Effectiveness-implementation Trial”. Addiction Science & Clinical Practice. Springer Science and Business Media LLC. doi:10.1186/s13722-021-00268-0.

clinicaltrials.govStudy

Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)

Sara Becker 2019. "Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03931174.

All > Opioid Dependence